Ignite Creation Date:
2024-05-05 @ 5:01 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00369226
Status:
COMPLETED
Last Update Posted:
2013-07-25
First Post:
2006-08-24
Brief Title:
Bortezomib Plus Tacrolimus and Methotrexate to Prevent Graft Versus Host Disease GVHD After Mismatched Allogeneic Non-Myeloablative Blood Stem Cell Transplantation
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-08
Start Date Type:
None
Primary Completion Date:
2010-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-09
Completion Date Type:
ACTUAL
First Submit Date:
2006-08-24
First Submit QC Date:
August 24 2006
Study First Post Date:
2006-08-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2013-07-25
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-06-19
Last Update Post Date:
2013-07-25
Last Update Post Date Type:
ESTIMATED